JPH04364109A - Hair tonic - Google Patents
Hair tonicInfo
- Publication number
- JPH04364109A JPH04364109A JP3233291A JP3233291A JPH04364109A JP H04364109 A JPH04364109 A JP H04364109A JP 3233291 A JP3233291 A JP 3233291A JP 3233291 A JP3233291 A JP 3233291A JP H04364109 A JPH04364109 A JP H04364109A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- oxide
- present
- phase
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 48
- 230000001256 tonic effect Effects 0.000 title abstract description 5
- 150000001204 N-oxides Chemical class 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 239000000126 substance Substances 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 22
- 150000001875 compounds Chemical class 0.000 abstract description 3
- XTIAYEYHRBGAFP-UHFFFAOYSA-N 2-methylpropyl 1-oxidopyridin-1-ium-3-carboxylate Chemical class CC(C)COC(=O)C1=CC=C[N+]([O-])=C1 XTIAYEYHRBGAFP-UHFFFAOYSA-N 0.000 abstract description 2
- DPWRGNWJVVSVIE-UHFFFAOYSA-N ethyl 1-oxidopyridin-1-ium-4-carboxylate Chemical compound CCOC(=O)C1=CC=[N+]([O-])C=C1 DPWRGNWJVVSVIE-UHFFFAOYSA-N 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 238000005507 spraying Methods 0.000 abstract 1
- -1 2-n-propoxycarbonylpyridine N-oxide Chemical compound 0.000 description 29
- 239000003795 chemical substances by application Substances 0.000 description 15
- 230000003779 hair growth Effects 0.000 description 13
- 201000004384 Alopecia Diseases 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 230000003676 hair loss Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 238000005342 ion exchange Methods 0.000 description 4
- 230000003658 preventing hair loss Effects 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical class CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 230000003797 telogen phase Effects 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- XMAAHVNXUIYSOV-UHFFFAOYSA-N 2-decyl-1-oxidopyridin-1-ium Chemical compound CCCCCCCCCCC1=CC=CC=[N+]1[O-] XMAAHVNXUIYSOV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- JFIOVJDNOJYLKP-UHFFFAOYSA-N bithionol Chemical compound OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O JFIOVJDNOJYLKP-UHFFFAOYSA-N 0.000 description 1
- 229960002326 bithionol Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- DJFVWKFPSAYARU-UHFFFAOYSA-N decyl 1-oxidopyridin-1-ium-3-carboxylate Chemical compound CCCCCCCCCCOC(=O)C1=CC=C[N+]([O-])=C1 DJFVWKFPSAYARU-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- JJVMERYWUXXDFJ-UHFFFAOYSA-N ethyl 1-oxidopyridin-1-ium-2-carboxylate Chemical compound CCOC(=O)C1=CC=CC=[N+]1[O-] JJVMERYWUXXDFJ-UHFFFAOYSA-N 0.000 description 1
- HPFQJBOXPBNOJK-UHFFFAOYSA-N ethyl 1-oxidopyridin-1-ium-3-carboxylate Chemical compound CCOC(=O)C1=CC=C[N+]([O-])=C1 HPFQJBOXPBNOJK-UHFFFAOYSA-N 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 230000003662 hair growth rate Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- XGHWESXDIVXZKH-UHFFFAOYSA-N methyl 1-oxidopyridin-1-ium-2-carboxylate Chemical compound COC(=O)C1=CC=CC=[N+]1[O-] XGHWESXDIVXZKH-UHFFFAOYSA-N 0.000 description 1
- RVBKAFFMAQAFGK-UHFFFAOYSA-N methyl 1-oxidopyridin-1-ium-3-carboxylate Chemical compound COC(=O)C1=CC=C[N+]([O-])=C1 RVBKAFFMAQAFGK-UHFFFAOYSA-N 0.000 description 1
- XSGNXRNOZMUURC-UHFFFAOYSA-N methyl 1-oxidopyridin-1-ium-4-carboxylate Chemical compound COC(=O)C1=CC=[N+]([O-])C=C1 XSGNXRNOZMUURC-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- YALNXMVGRGXQHW-UHFFFAOYSA-N tert-butyl 1-oxidopyridin-1-ium-2-carboxylate Chemical compound CC(C)(C)OC(=O)C1=CC=CC=[N+]1[O-] YALNXMVGRGXQHW-UHFFFAOYSA-N 0.000 description 1
- GVMCXCBWVPBAJA-UHFFFAOYSA-N tert-butyl 1-oxidopyridin-1-ium-4-carboxylate Chemical compound CC(C)(C)OC(=O)C1=CC=[N+]([O-])C=C1 GVMCXCBWVPBAJA-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は優れた脱毛防止、発毛効
果等の養毛作用を持つ養毛料に関する。本発明は、特に
医薬品、或は医薬部外品、化粧品分野において利用され
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair nourishing agent that has excellent hair nourishing effects such as hair loss prevention and hair growth effects. The present invention is particularly useful in the fields of pharmaceuticals, quasi-drugs, and cosmetics.
【0002】0002
【従来の技術】従来より、禿や脱毛の原因としては、毛
根、皮脂腺等の器官における男性ホルモンの活性化、毛
包への血流量の低下、皮脂の分泌過剰、過酸化物の生成
等による頭皮の異常等が考えられている。このため従来
の養毛料には、前記の原因を取り除いたり、または、軽
減する作用を持つ化合物が一般に配合されている。[Prior Art] Conventionally, the causes of baldness and hair loss include activation of male hormones in organs such as hair roots and sebaceous glands, decreased blood flow to hair follicles, excessive secretion of sebum, and production of peroxides. Scalp abnormalities are suspected. For this reason, conventional hair nourishing products generally contain compounds that have the effect of eliminating or alleviating the above-mentioned causes.
【0003】例えば、ビタミンB潸、ビタミンE等のビ
タミン類、セリン、メチオニン等のアミノ酸類、センブ
リエキス、アセチルコリン誘導体などの血管拡張剤、紫
根エキス、ヒノキチオール等の抗炎症剤、エストラジオ
ールなどの女性ホルモン剤、セファランチンなどの皮膚
機能亢進剤などが配合され、脱毛症の予防および治療に
用いられている。[0003] For example, vitamins such as vitamin B and vitamin E, amino acids such as serine and methionine, vasodilators such as Oriental japonica extract and acetylcholine derivatives, purple root extract, anti-inflammatory agents such as hinokitiol, and female hormones such as estradiol. It is used to prevent and treat alopecia, and is used to prevent and treat alopecia.
【0004】0004
【発明が解決しようとする課題】従来技術の問題点しか
しながら、従来の養毛料はフケ、カユミ、脱毛などの予
防および改善に有効で、発毛や育毛を促進するとされて
いるが、脱毛や発毛の機構は非常に複雑であり、従来の
養毛料による男性ホルモンの活性化の阻害や毛包への血
流量の増加だけでは、充分な脱毛防止、発毛効果は認め
られなかった。[Problems to be Solved by the Invention] Problems with the Prior Art However, conventional hair nourishing agents are said to be effective in preventing and improving dandruff, itching, hair loss, etc. and to promote hair growth. The mechanism of hair is extremely complex, and it has not been possible to achieve sufficient hair loss prevention or hair growth effects simply by inhibiting the activation of male hormones or increasing blood flow to hair follicles using conventional hair tonics.
【0005】発明の目的
本発明者は、上記の事情に鑑み、脱毛に対して有効であ
り、優れた脱毛防止、発毛効果等の養毛作用を持つ物質
を探求した結果、下記一般式、化Iで示されるアルコキ
シカルボニルピリジン N−オキシドが強力な養毛作用
を持つことを見出し、本発明を完成するに至った。Purpose of the Invention In view of the above circumstances, the present inventor has searched for a substance that is effective against hair loss and has excellent hair growth prevention and hair growth effects, and has found the following general formula: The present inventors have discovered that alkoxycarbonylpyridine N-oxide represented by formula I has a strong hair-nourishing effect, and have completed the present invention.
【0006】[0006]
【化I】(式中、Rは炭素数2〜17の直鎖あるいは分
枝のアルキル基を表す。)[Chemical formula I] (wherein, R represents a straight chain or branched alkyl group having 2 to 17 carbon atoms.)
【0007】[0007]
【課題を解決するための手段】すなわち、本発明は下記
一般式、化Iで示されるアルコキシカルボニルピリジン
N−オキシドの一種または二種以上を有効成分として配
合することを特徴とする養毛料である。[Means for Solving the Problems] That is, the present invention is a hair nourishing agent characterized by containing one or more alkoxycarbonylpyridine N-oxides represented by the following general formula and formula I as an active ingredient. .
【0008】[0008]
【化I】(式中、Rは炭素数2〜17の直鎖あるいは分
枝のアルキル基を表す。)以下、本発明の構成について
詳述する。[Formula I] (In the formula, R represents a straight chain or branched alkyl group having 2 to 17 carbon atoms.) The structure of the present invention will be explained in detail below.
【0009】本発明で使用するアルコキシカルボニルピ
リジン N−オキシドは下記一般式、化IThe alkoxycarbonylpyridine N-oxide used in the present invention has the following general formula:
【0010】0010
【化I】(式中、Rは炭素数2〜17の直鎖あるいは分
枝のアルキル基を表す。)[Chemical formula I] (wherein, R represents a straight chain or branched alkyl group having 2 to 17 carbon atoms.)
【0011】で示される化合物で、化学名で言うと2−
メトキシカルボニルピリジン N−オキシド、3−メト
キシカルボニルピリジン N−オキシド、4−メトキシ
カルボニルピリジン N−オキシド、2−エトキシカル
ボニルピリジン N−オキシド、3−エトキシカルボニ
ルピリジン N−オキシド、4−エトキシカルボニルピ
リジン N−オキシド、2−n−プロポキシカルボニル
ピリジン N−オキシド、3−iso−プロポキシカル
ボニルピリジン N−オキシド、4−tert−ブトキ
シカルボニルピリジン N−オキシド、2−n−ブトキ
シカルボニルピリジンN−オキシド、3−iso−ブト
キシカルボニルピリジン N−オキシド、2−tert
−ブトキシカルボニルピリジンN−オキシド、2−is
o−ペンチルオキシカルボニルピリジン N−オキシド
、4−ネオペンチルオキシカルボニルピリジンN−オキ
シド、2−n−ペンチルオキシカルボニルピリジン N
−オキシド、2−ネオペンチルオキシカルボニルピリジ
ン N−オキシド、2−n−ヘキシルオキシカルボニル
ピリジン N−オキシド、2−n−ヘプチルオキシカル
ボニルピリジン N−オキシド、2−オクチルオキシカ
ルボニルピリジン N−オキシド、4−オクチルオキシ
カルボニルピリジン N−オキシド、4−(1−メチル
ヘプチルオキシカルボニル)ピリジン N−オキシド、
2−n−ノニルオキシカルボニルピリジン N−オキシ
ド、2−(2−メチルオクチルオキシカルボニル)ピリ
ジン N−オキシド、2−(1−ブチルペンチルオキシ
カルボニル)ピリジン N−オキシド、4−n−ノニル
オキシカルボニルピリジンN−オキシド、4−(1−ブ
チルペンチルオキシカルボニル)ピリジン N−オキシ
ド、2−n−デシルピリジン N−オキシド、3−n−
デシルオキシカルボニルピリジンN−オキシド、4−n
−デシルオキシカルボニルピリジン N−オキシド、2
−n−ウンデシルオキシカルボニルピリジン N−オキ
シド、4−n−ドデシルオキシカルボニルピリジン N
−オキシド、2−n−トリデシルオキシカルボニルピリ
ジン N−オキシド、3−n−トリデシルオキシカルボ
ニルピリジン N−オキシド、4−n−トリデシルオキ
シカルボニルピリジン N−オキシド、2−n−ヘプタ
デシルオキシカルボニルピリジン N−オキシド、4−
n−ヘプタデシルオキシカルボニルピリジン N−オキ
シド、2−(1−オクチルノニルオキシカルボニル)ピ
リジン N−オキシド等である。The chemical name of the compound is 2-
Methoxycarbonylpyridine N-oxide, 3-methoxycarbonylpyridine N-oxide, 4-methoxycarbonylpyridine N-oxide, 2-ethoxycarbonylpyridine N-oxide, 3-ethoxycarbonylpyridine N-oxide, 4-ethoxycarbonylpyridine N- oxide, 2-n-propoxycarbonylpyridine N-oxide, 3-iso-propoxycarbonylpyridine N-oxide, 4-tert-butoxycarbonylpyridine N-oxide, 2-n-butoxycarbonylpyridine N-oxide, 3-iso- Butoxycarbonylpyridine N-oxide, 2-tert
-butoxycarbonylpyridine N-oxide, 2-is
o-pentyloxycarbonylpyridine N-oxide, 4-neopentyloxycarbonylpyridine N-oxide, 2-n-pentyloxycarbonylpyridine N
-oxide, 2-neopentyloxycarbonylpyridine N-oxide, 2-n-hexyloxycarbonylpyridine N-oxide, 2-n-heptyloxycarbonylpyridine N-oxide, 2-octyloxycarbonylpyridine N-oxide, 4- Octyloxycarbonylpyridine N-oxide, 4-(1-methylheptyloxycarbonyl)pyridine N-oxide,
2-n-nonyloxycarbonylpyridine N-oxide, 2-(2-methyloctyloxycarbonyl)pyridine N-oxide, 2-(1-butylpentyloxycarbonyl)pyridine N-oxide, 4-n-nonyloxycarbonylpyridine N-oxide, 4-(1-butylpentyloxycarbonyl)pyridine N-oxide, 2-n-decylpyridine N-oxide, 3-n-
Decyloxycarbonylpyridine N-oxide, 4-n
-decyloxycarbonylpyridine N-oxide, 2
-n-undecyloxycarbonylpyridine N-oxide, 4-n-dodecyloxycarbonylpyridine N
-oxide, 2-n-tridecyloxycarbonylpyridine N-oxide, 3-n-tridecyloxycarbonylpyridine N-oxide, 4-n-tridecyloxycarbonylpyridine N-oxide, 2-n-heptadecyloxycarbonyl Pyridine N-oxide, 4-
These include n-heptadecyloxycarbonylpyridine N-oxide, 2-(1-octylnonyloxycarbonyl)pyridine N-oxide, and the like.
【0012】本発明で使用するアルコキシカルボニルピ
リジン N−オキシドは公知の方法で得られるものであ
り、その配合量は本発明の養毛料中、0.001〜20
重量%、好ましくは0.1〜10重量%である。[0012] The alkoxycarbonylpyridine N-oxide used in the present invention is obtained by a known method, and the amount of the alkoxycarbonylpyridine N-oxide contained in the hair nourishment of the present invention is 0.001 to 20
% by weight, preferably from 0.1 to 10% by weight.
【0013】本発明に係る養毛料にはアルコキシカルボ
ニルピリジン N−オキシドのほか、塩化カルプロニウ
ム、センブリエキス、アセチルコリン誘導体等の血管拡
張剤、セリン、メチオニン等のアミノ酸類、ビタミンB
潸、ビタミンE及びその誘導体、ビオチン等のビタミン
類、パントテン酸及びその誘導体、グリチルレチン酸及
びその誘導体、ニコチン酸ベンジルなどのニコチン酸エ
ステル類、セファランチン等の皮膚機能亢進剤、エスト
ラジオール等の女性ホルモン剤等を同時に配合してもよ
い。さらに、通常、養毛料に用いられる添加剤、例えば
、ヒノキチオール、ヘキサクロロフェン、ベンザルコニ
ウムクロリド、セチルピリジニウムクロリド、ウンデシ
レン酸、トリクロロカルバニリドおよびビチオノール等
の抗菌剤、メントール等の清涼剤、サリチル酸、亜鉛お
よびその誘導体、乳酸およびそのアルキルエステル等の
薬剤、クエン酸等の有機酸類、トラネキサム酸等のプロ
テア−ゼ阻害剤、アルギニン等のアミノ酸類、オリーブ
油、スクワラン、流動パラフィン、イソプロピルミリス
テート、高級脂肪酸、高級アルコール等の油分、グリセ
リン、プロピレングリコール等の多価アルコール、その
他界面活性剤、香料、酸化防止剤、紫外線吸収剤、色素
、エタノール、水、保湿剤、増粘剤等が本発明の効果を
損なわない範囲で適宜配合することができる。[0013] In addition to alkoxycarbonylpyridine N-oxide, the hair nourishment according to the present invention contains vasodilators such as carpronium chloride, Oriental japonica extract, and acetylcholine derivatives, amino acids such as serine and methionine, and vitamin B.
vitamins such as vitamin E and its derivatives, biotin, pantothenic acid and its derivatives, glycyrrhetinic acid and its derivatives, nicotinic acid esters such as benzyl nicotinate, skin function enhancers such as cephalanthine, and female hormones such as estradiol. etc. may be blended at the same time. Furthermore, additives normally used in hair nourishing agents, such as hinokitiol, hexachlorophene, benzalkonium chloride, cetylpyridinium chloride, antibacterial agents such as undecylenic acid, trichlorocarbanilide and bithionol, cooling agents such as menthol, salicylic acid, Zinc and its derivatives, drugs such as lactic acid and its alkyl esters, organic acids such as citric acid, protease inhibitors such as tranexamic acid, amino acids such as arginine, olive oil, squalane, liquid paraffin, isopropyl myristate, higher fatty acids , oils such as higher alcohols, polyhydric alcohols such as glycerin and propylene glycol, other surfactants, fragrances, antioxidants, ultraviolet absorbers, pigments, ethanol, water, humectants, thickeners, etc., have the effects of the present invention. It can be blended as appropriate within a range that does not impair the properties.
【0014】本発明の養毛料の性状は、液状、乳液、軟
膏等外皮に適用できる性状のものであればいずれでもよ
い。本発明の養毛料は皮膚に直接に塗布または散布する
経皮投与による投与方法をとる。また、本発明の養毛料
の投与量は、年齢、個人差、病状等により変化するので
明確には確定できないが、一般に人に投与する場合の投
与量は体重1kgおよび1日当り0.01〜100mg
、好ましくは0.1〜10mgであり、この量を1日1
回または2〜4回に分けて投与することができる。The hair nourishment of the present invention may be in any form as long as it can be applied to the skin, such as liquid, milky lotion, or ointment. The hair growth agent of the present invention is administered by transdermal administration, in which it is directly applied or sprayed onto the skin. Furthermore, the dosage of the hair nourishment of the present invention cannot be clearly determined as it varies depending on age, individual differences, medical conditions, etc., but in general, the dosage when administered to humans is 0.01 to 100 mg per kg of body weight and per day.
, preferably 0.1 to 10 mg, and this amount is administered once a day.
It can be administered once or in 2 to 4 divided doses.
【0015】[0015]
【発明の効果】本発明の養毛料は優れた脱毛防止、発毛
効果等の養毛作用を持つ養毛料である。Effects of the Invention The hair nourishing agent of the present invention has excellent hair nourishing effects such as hair loss prevention and hair growth effects.
【0016】[0016]
【実施例】次に実施例をあげて本発明の養毛料の製法お
よび養毛作用をさらに具体的に説明する。本発明はこれ
により限定されるものではない。配合量は重量%である
。
(製造法)95%エタノールにアルコキシカルボニルピ
ジリン N−オキシドおよび硬化ヒマシ油エチレンオキ
シド(40モル)付加物を添加し、攪拌溶解させ、次い
でイオン交換水を添加、混合して実施例1の液状の養毛
料を得た。実施例2〜15並びに比較例1も実施例1と
同様にして得た。EXAMPLES Next, the method for producing the hair nourishing agent and the hair nourishing effect of the present invention will be explained in more detail with reference to Examples. The present invention is not limited thereby. The blending amount is in weight%. (Production method) Add alkoxycarbonylpidiline N-oxide and hydrogenated castor oil ethylene oxide (40 mol) adduct to 95% ethanol, stir and dissolve, then add ion-exchanged water and mix to prepare the liquid of Example 1. I got hair nourishment. Examples 2 to 15 and Comparative Example 1 were also obtained in the same manner as Example 1.
【0017】[0017]
【表1】[Table 1]
【0018】[0018]
【表2】[Table 2]
【0019】[0019]
【表3】[Table 3]
【0020】[発毛試験]実施例1〜28および比較例
1の発毛試験を毛周期の休止期にあるC3H/HeNC
rJマウスを用い、小川らの方法(ノーマルアンド
アブノーマル エピダーマル ディファレンシェー
ション Normal and Abnormal E
pidermal Differentiation
、M.SeijiおよびI.A.Bernstein編
集、第159〜170ページ、1982年、東大出版)
により行なった。すなわち、マウスを1群10匹とし、
無塗布、実施例1〜15および比較例1の30群に分け
、バリカンおよびシェーバーでマウスの背部を剃毛し、
それぞれのサンプルを1日1回、0.1 mlずつ塗布
した。各サンプルの発毛効果はマウス背部の発毛部分を
測定して面積比によって比較した。各サンプルによる5
0%発毛率に要する日数を表4に示した。[Hair growth test] The hair growth tests of Examples 1 to 28 and Comparative Example 1 were conducted using C3H/HeNC in the resting phase of the hair cycle.
Using rJ mice, Ogawa et al.'s method (normal and
Abnormal Epidermal Difference Normal and Abnormal E
Pidermal Differentiation
,M. Seiji and I. A. Bernstein (ed., pages 159-170, 1982, University of Tokyo Press)
This was done by That is, 10 mice per group,
The mice were divided into 30 groups: no application, Examples 1 to 15, and Comparative Example 1, and the backs of the mice were shaved with clippers and a shaver.
0.1 ml of each sample was applied once a day. The hair growth effect of each sample was compared by measuring the hair growth area on the back of the mouse and comparing the area ratio. 5 for each sample
Table 4 shows the number of days required for 0% hair growth rate.
【0021】[0021]
【表4】[Table 4]
【0022】以上のように、本発明に係わる養毛料は、
優れた発毛効果を有している。
[養毛作用試験]次に本発明の養毛料の脱毛防止、発毛
効果等の養毛作用を調べるために、人に対して、トリコ
グラム試験を実施した。実施例1〜15、比較例1の養
毛料について行なった。
(トリコグラム試験)養毛料の使用前と使用後の抜去毛
髪の毛根を顕微鏡下で観察し、毛根の形態から休止期毛
根数を計数し、その割合の増減によって養毛料の養毛作
用を比較した。休止期毛根とは成長の止まった毛の毛根
であり、脱毛を訴える人は正常な人よりもこの休止期毛
根の割合が多いことが認められている。実施例1〜15
および比較例1の各養毛料をそれぞれ男性被験者10名
の頭皮に1日2回、1回2mlずつ6カ月間連続して塗
布し、塗布直前および6カ月間塗布終了直後に被験者1
名につき100本ずつ毛髪を抜去し、それぞれの毛根を
調べた。
結果を表5に示した。As mentioned above, the hair nourishment according to the present invention is
It has an excellent hair growth effect. [Hair nourishing effect test] Next, in order to examine the hair nourishing effects of the hair nourishing agent of the present invention, such as hair loss prevention and hair growth effects, a tricogram test was conducted on humans. The test was performed on the hair nourishing products of Examples 1 to 15 and Comparative Example 1. (Trichogram test) Observe the removed hair roots under a microscope before and after using the hair nourishing agent, count the number of resting hair roots based on the shape of the hair root, and compare the hair nourishing effect of the hair nourishing agent by increasing or decreasing the ratio. did. Telogen hair roots are hair roots that have stopped growing, and it is recognized that people who complain of hair loss have a higher proportion of hair roots in the telogen phase than normal people. Examples 1-15
Each hair nourishing agent of Comparative Example 1 was applied to the scalps of 10 male subjects twice a day at a rate of 2 ml at a time for 6 consecutive months.
100 hairs per person were removed and the root of each hair was examined. The results are shown in Table 5.
【0023】[0023]
【表17】以上のように本発明に係る養毛料は、優れた
養毛作用を有している。[Table 17] As described above, the hair nourishing agent according to the present invention has an excellent hair nourishing effect.
【0024】
実施例16
重量%(A 相)
3−フ゛トキシカルホ゛ニルヒ゜リシ゛ン N−オ
キシト゛
1.0 ホ゜リオキシエ
チレン(60モル)付加硬化ヒマシ油
2.0
グリセリン
10.0 ジプロピレングリコール
10.0 1,3−ブチレング
リコール
5.0 ポリエチ
レングリコール1500
5.0
(B 相)
セチルイソオクタネート
10.0 スクワラン
5.0 ワセリン
2.0 プロピルパラベン
2.0 (C 相)
カルボキシビニルポリマー1%水溶液
30.0
ヘキサメタリン酸ソーダ
0.03 イオン交換水
8.35(D 相)
イオン交換水
4.5 (E 相)
カセイカリ
0.12 イオン交換水
5.0 (製
造法)A相、B相をそれぞれ60℃で加熱溶解し、混合
してホモミキサー処理しゲルを作る。これにD相を徐々
に添加しホモミキサーで分散する。次にこれに溶解した
C相を加え、最後に溶解したE相を添加しホモミキサー
で乳化してo/w乳液型の養毛料を得た。この養毛料を
実施例1と同様に人に対して、実使用テストを行ったと
ころ、その養毛作用が優れていることが確認された。Example 16
Weight% (Phase A) 3-phytoxycarboxylic acid N-oxyto
1.0 Polyoxyethylene (60 mol) addition-hardened castor oil
2.0
glycerin
10.0 Dipropylene glycol
10.0 1,3-butylene glycol
5.0 Polyethylene glycol 1500
5.0
(Phase B) Cetyl isooctanate
10.0 Squalane
5.0 Vaseline
2.0 Propylparaben
2.0 (C phase) 1% carboxyvinyl polymer aqueous solution
30.0
Sodium hexametaphosphate
0.03 Ion exchange water
8.35 (D phase) Ion exchange water
4.5 (E phase) Caustic potash
0.12 Ion exchange water
5.0 (Manufacturing method) Phase A and phase B are heated and dissolved at 60°C, mixed and treated with a homomixer to form a gel. Phase D is gradually added to this and dispersed using a homomixer. Next, the dissolved phase C was added thereto, and finally the dissolved phase E was added and emulsified with a homomixer to obtain an o/w emulsion type hair nourishment. When this hair nourishing agent was tested on humans in the same manner as in Example 1, it was confirmed that its hair nourishing effect was excellent.
【0025】
実施例17
重量%(A 相)
4−イソフ゜ロホ゜キシカルホ゛ニルヒ゜リシ゛ン
N−オキシト゛
2.0 流動パラフ
ィン
5.0 セトステアリルアルコール
5.5 グリセリルモノステアレート
3.0 EO(20モル)−2−
オクチルドデシルエーテル
3.0 プロピルパラ
ベン
0.
3 香料
0.1(B 相)
グリセリン
8.0 ジプロピレングリコール
20.0 ポリエチレ
ングリコール4000
5.0
ヘキサメタリン酸ソーダ
0.005 イオン交換水
48.095(製造法)A相、B
相をそれぞれ加熱溶解して混合し、ホモミキサーで乳化
してクリーム状養毛料を得た。この養毛料を実施例1と
同様に人に対して、実使用テストを行ったところ、その
養毛効果が優れていることが確認された。Example 17
Weight % (Phase A) 4-Isopropyrooxycarboxylic acid N-oxyto
2.0 Liquid paraffin
5.0 Cetostearyl alcohol
5.5 Glyceryl monostearate
3.0 EO (20 mol)-2-
Octyl dodecyl ether
3.0 Propylparaben
0.
3 Fragrance
0.1 (B phase) Glycerin
8.0 Dipropylene glycol
20.0 Polyethylene glycol 4000
5.0
Sodium hexametaphosphate
0.005 Ion exchange water
48.095 (Manufacturing method) Phase A, B
The phases were dissolved and mixed by heating, and the mixture was emulsified using a homomixer to obtain a creamy hair nourishing agent. When this hair nourishing agent was tested on humans in the same manner as in Example 1, it was confirmed that the hair nourishing effect was excellent.
【化1】[Chemical formula 1]
【表5】[Table 5]
Claims (1)
ルボニルピリジン N−オキシドの一種または二種以上
を有効成分として配合することを特徴とする養毛料。 【化I】(式中、Rは炭素数2〜17の直鎖あるいは分
枝のアルキル基を表す。)1. A hair nourishing composition comprising one or more alkoxycarbonylpyridine N-oxides represented by the following general formula and formula I as an active ingredient. [Chemical formula I] (wherein, R represents a straight chain or branched alkyl group having 2 to 17 carbon atoms.)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3233291A JPH04364109A (en) | 1991-01-31 | 1991-01-31 | Hair tonic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3233291A JPH04364109A (en) | 1991-01-31 | 1991-01-31 | Hair tonic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04364109A true JPH04364109A (en) | 1992-12-16 |
Family
ID=12355995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3233291A Pending JPH04364109A (en) | 1991-01-31 | 1991-01-31 | Hair tonic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04364109A (en) |
-
1991
- 1991-01-31 JP JP3233291A patent/JPH04364109A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100616342B1 (en) | Hair tonic composition | |
JP3220761B2 (en) | Hair restoration | |
KR910010018B1 (en) | Hair tonic | |
JPH11269043A (en) | Cosmetic for scalp and hair | |
JPH09241137A (en) | Hair crowing and restoring agent | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JP2566792B2 (en) | Hair growth and hair growth promoter | |
JPH0640858A (en) | Hair tonic | |
JP2998939B2 (en) | Hair restoration | |
JPH04364109A (en) | Hair tonic | |
JP2814090B2 (en) | Hair restoration | |
JPH0352806A (en) | Hair-raising agent | |
JP2787451B2 (en) | Hair restoration | |
JPH02164813A (en) | Hair tonic | |
JP2961528B2 (en) | Hair restoration | |
JPH07206647A (en) | Hair tonic | |
JPH04364108A (en) | Hair tonic | |
JP2791567B2 (en) | Hair restoration | |
JPH05124937A (en) | Hair tonic | |
JPH10273423A (en) | Cosmetic for hair | |
JP3639389B2 (en) | Hair nourishing | |
JP4327989B2 (en) | Hair cosmetics | |
JPH07149614A (en) | Hair tonic agent | |
JPH0390014A (en) | Hair tonic | |
JPH03178918A (en) | Hair tonic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20000107 |